TITLE

Basic mechanisms in acute lung injury

PUB. DATE
December 2006
SOURCE
Thorax;Dec2006 Supplement 2, Vol. 61, pii50
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents abstracts of several studies on basic mechanisms in acute lung injury. They include "Differential Effects of Vascular Endothelial Growth Factor Isoforms on Primary Human Lung Microvascular Endothelial Cell Proliferation," "Heme Oxygenase-1 is Induced in Human Neutrophils Following Surgery Requiring Cardiopulmonary Bypass," and "Pulmonary Fibrosis is an Early Feature of Acute Lung Injury/Acute Respiratory Distress Syndrome."
ACCESSION #
23488495

 

Related Articles

  • Sequestration of Vascular Endothelial Growth Factor (VEGF) Induces Late Restrictive Lung Disease. Wieck, Minna M.; Spurrier, Ryan G.; Levin, Daniel E.; Mojica, Salvador Garcia; Hiatt, Michael J.; Reddy, Raghava; Hou, Xiaogang; Navarro, Sonia; Lee, Jooeun; Lundin, Amber; Driscoll, Barbara; Grikscheit, Tracy C. // PLoS ONE;2/10/2016, Vol. 11 Issue 2, p1 

    Rationale: Neonatal respiratory distress syndrome is a restrictive lung disease characterized by surfactant deficiency. Decreased vascular endothelial growth factor (VEGF), which demonstrates important roles in angiogenesis and vasculogenesis, has been implicated in the pathogenesis of...

  • Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe? Papaioannou, Andriana I.; Kostikas, Konstantinos; Kollia, Panagoula; Gourgoulianis, Konstantinos I. // Respiratory Research;2006, Vol. 7, p1 

    Vascular endothelial growth factor (VEGF) is a potent mediator of angiogenesis which has multiple effects in lung development and physiology. VEGF is expressed in several parts of the lung and the pleura while it has been shown that changes in its expression play a significant role in the...

  • Heme Oxygenase-1/Carbon Monoxide: Novel Therapeutic Strategies in Critical Care Medicine. Ryter, Stefan W.; Choi, Augustine M. K. // Current Drug Targets;Dec2010, Vol. 11 Issue 12, p1485 

    No abstract available.

  • Surfactant Protein A - From Genes to Human Lung Diseases. Heinrich, S.; Hartl, D.; Griese, M. // Current Medicinal Chemistry;2006, Vol. 13 Issue 27, p3239 

    Surfactant associated protein-A (SP-A) is the most abundant pulmonary surfactant protein and belongs to the family of innate host defense proteins termed collectins. Besides pulmonary host defense, SP-A is also involved in the formation of pulmonary surfactant, as it is essential for the...

  • Pulmonary Surfactant Proteins A and D: Innate Immune Functions and Biomarkers for Lung Diseases. Takahashi, Hiroki; Sano, Hitomi; Chiba, Hirofumi; Kuroki, Yoshio // Current Pharmaceutical Design;Feb2006, Vol. 12 Issue 5, p589 

    Pulmonary surfactant, a complex of lipids and proteins, functions to keep alveoli from collapsing at expiration. Surfactant proteins A (SP-A) and D (SP-D) belong to the collectin family and play pivotal roles in the innate immunity of the lung. Pulmonary collectins directly bind with broad...

  • Idiopathic desquamative interstitial pneumonia in a child: a case report. Bressieux-Degueldre, Sabrina; Rotman, Samuel; Hafen, Gaudenz; Aubert, John-David; Rochat, Isabelle // BMC Research Notes;2014, Vol. 7 Issue 1, p2 

    Background Desquamative interstitial pneumonia is a rare form of interstitial lung disease in children. Respiratory symptoms appear progressively, are often subtle, and diagnosis is often delayed by a mean of 6 months after onset. High resolution chest computed tomography is the most sensitive...

  • Acute Interstitial Pneumonia (Hamman-Rich Syndrome) as a Cause of Idiopathic Acute Respiratory Distress Syndrome. Bruminhent, Jackrapong; Yassir, Shahla; Pippim, James // Case Reports in Medicine;2011, p1 

    Hamman-Rich syndrome, also known as acute interstitial pneumonia, is a rare and fulminant form of idiopathic interstitial lung disease. It should be considered as a cause of idiopathic acute respiratory distress syndrome. Confirmatory diagnosis requires demonstration of diffuse alveolar damage...

  • Serum levels of vascular endothelial growth factor in chronic obstructive pulmonary disease. Hosseini, Reza Farid; Azad, Farahzad Jabbari; Hadis, Yousefzadeh; Rafatpanah, Houshang; Hafizi, Saeed; Tehrani, Homan; Khani, Masoud // Medical Journal of the Islamic Republic of Iran;2014, Vol. 28, p1 

    Background: Chronic obstructive pulmonary disease (COPD) is a third leading cause of death. Methods: In this case control study, we prepared 5 cc bloods from the antecubital vein of 100 COPD patients and 40 healthy individuals as control group. Vascular endothelial growth factor (VEGF)...

  • Assessment of Cord Blood Vascular Endothelial Growth Factor Levels and Circulating CD34+ Cells in Preterm Infants with Respiratory Distress Syndrome. Moawed, Azza Tawfeek; El Nashar, Nihad Ahmed; El Margoushy, Nesriene Mohamed // Egyptian Journal of Hospital Medicine;Apr2012, Vol. 47, p166 

    Background: Respiratory distress syndrome (RDS) secondary to surfactant deficiency is a common cause of mobility and mortality in premature infants. Vascular endothelial growth factor (VEGF) is a major angiogenic factor and prime regulator of endothelial cells proliferation. So, VEGF may...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics